Cargando…
A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer
Bladder cancer (BLCA) is one of the most prevalent and heterogeneous urinary malignant tumors. Previous researches have reported a significant association between cancer-associated fibroblasts (CAFs) and poor prognosis of tumor patients. However, uncertainty surrounds the role of CAFs in the BLCA tu...
Autores principales: | Qin, Yiming, Zu, Xiongbing, Li, Yin, Han, Ying, Tan, Jun, Cai, Changjing, Shen, Edward, Liu, Ping, Deng, Ganlu, Feng, Ziyang, Wu, Wantao, Peng, Yinghui, Liu, Yongting, Ma, Jiayao, Zeng, Shan, Chen, Yihong, Shen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485638/ https://www.ncbi.nlm.nih.gov/pubmed/37694141 http://dx.doi.org/10.1016/j.isci.2023.107722 |
Ejemplares similares
-
Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022) -
Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
por: Gao, Yan, et al.
Publicado: (2022) -
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
por: Cai, Changjing, et al.
Publicado: (2022) -
RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
por: Liu, Yongting, et al.
Publicado: (2023) -
MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma
por: Huang, Qiaoqiao, et al.
Publicado: (2022)